Janssen, BI fund AFib ed. initiative

Share this article:

The North American Thrombosis Forum (NATF) launched an educational initiative on risk assessment and anticoagulation for stroke prevention in atrial fibrillation (AF).

The initiative is sponsored in part by Janssen Pharmaceuticals, which markets oral anticoagulant Xarelto, and by Boehringer Ingelheim, which sells warfarin replacement med Pradaxa.

The goal of the three-year project, according to a statement, is to convene a consensus group of expert researchers and clinicians in the US, Canada, and Europe to synthesize recent clinical trial data and guideline recommendations into one comprehensive and concise “briefing document” for education and reference for the entire medical community involved in the care of patients with AF. The mission is also to provide recommendations regarding anticoagulation options and management.

“There has been an explosion of recent data,” said the leader of the effort Christian Ruff, MD, MPH, an associate physician in the cardiovascular division at Brigham and Women's Hospital. However, he added, “there's a real disconnect between the exciting clinical trial data and real-world practical advice for local healthcare providers and nurses and patients.”

A micro-site hosts resources created as part of the ongoing project, including video interviews with leading clinical experts and risk stratification tools.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.